Screening Study for Participants With Malignant Tumors
The study objective is to determine the biomarker status of a participant's tumor tissue and use that status to determine eligibility for a linked Roche clinical trial.
Solid Tumors
OTHER: Screening platform
Proportion of participants with evaluable biomarker results, Up to 10 years|Proportion of participants eligible for a linked Roche clinical trial, Up to 10 years
The study objective is to determine the biomarker status of a participant's tumor tissue and use that status to determine eligibility for a linked Roche clinical trial.